Post-earnings recap
Reported
Mon, Oct 20, 2014
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Illumina's earnings report showed a strong EPS beat, which indicates better-than-expected profitability. However, the stock reacted negatively, declining by 0.27%. The lack of revenue details and future guidance may have contributed to investor caution.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.77 | N/A | +38.49% |
| Revenue | N/A | N/A | N/A |
Management expressed confidence in the company's growth driven by new products. However, they did not provide specific guidance for the upcoming quarters.
Management highlighted strong performance in genetic sequencing.
They emphasized ongoing investments in innovation.
There was no specific guidance provided for future quarters.